04/18/2024
3:19 PM | Taysha Gene Therapies (Filer)
| Form ARS | |
04/18/2024
3:21 PM | Taysha Gene Therapies (Filer)
| Form DEFA14A | |
03/19/2024
3:55 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
7:44 PM | Taysha Gene Therapies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
6:08 AM | RTW INVESTMENTS, LP (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
02/06/2024
3:42 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
01/10/2024
7:06 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:41 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:42 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:43 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:20 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/20/2023
3:21 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:50 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:46 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
6:35 AM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:29 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:47 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:17 PM | Taysha Gene Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
3:40 PM | Long Alison S (Reporting)
Taysha Gene Therapies (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/03/2023
3:41 PM | Long Alison S (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
6:00 AM | Taysha Gene Therapies (Filer)
| Form DEF 14A | |
09/26/2023
7:08 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
3:01 PM | Taysha Gene Therapies (Filer)
| Form PRE 14A | |
09/11/2023
7:23 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
09/10/2023
11:15 PM | Taysha Gene Therapies (Filer)
| Form EFFECT | |
08/29/2023
6:00 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
4:01 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
08/25/2023
3:30 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:33 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/24/2023
7:09 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
4:16 PM | Astellas Pharma Inc. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13D/A | |
08/16/2023
7:57 PM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:51 PM | Donenberg Phillip B. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:52 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:53 PM | Stalfort John A III (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
7:36 AM | Taysha Gene Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:29 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
7:05 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
3:00 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/28/2023
7:31 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
3:48 PM | Stalfort John A III (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:49 PM | Donenberg Phillip B. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:50 PM | Reape Kathleen (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:50 PM | Sepp-Lorenzino Laura (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:46 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:46 PM | Stalfort John A III (Reporting)
Taysha Gene Therapies (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2023
4:27 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
4:12 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
6:14 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Subject)
| Form 144/A | |
06/20/2023
3:52 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
7:20 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
8:24 PM | Porter Fred (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
8:25 PM | McAuliffe Sean (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
7:28 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
3:44 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
5:15 PM | McGinnis Emily (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2023
11:15 PM | Taysha Gene Therapies (Filer)
| Form EFFECT | |
